Caristo Diagnostics Gains AMA Approval for AI Heart Disease Tool

Caristo Diagnostics Gains AMA Approval for AI Heart Disease Tool

Caristo Diagnostics has received AMA approval for new CPT codes for its AI-powered CaRi-Heart technology, marking a significant step towards its clinical adoption.

Caristo Diagnostics has achieved a significant milestone with the American Medical Association (AMA) approving new Category III CPT codes for its AI-powered CaRi-Heart technology. Announced in a press release, this approval is a crucial step towards integrating the technology into routine clinical care in the U.S.

The CaRi-Heart tool is designed to detect coronary inflammation from routine CT scans, offering a new approach to cardiac risk assessment by revealing biological drivers of heart disease. This advancement allows for proactive, AI-driven risk assessment, potentially transforming preventive cardiology by enabling earlier intervention.

The newly approved CPT codes, X409T and add-on code X434T, will be published on the AMA website by July 2025 and become effective on January 1, 2026. This approval comes ahead of the CaRi-Heart market launch schedule, supported by medical societies like the American College of Cardiology, highlighting the growing consensus on the importance of coronary inflammation as a risk factor for heart attacks.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more